Cencora, Inc.’s $4.5 Billion Revolving Credit Facility
June 18, 2025
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4.5 billion revolving credit facility made available to Cencora, Inc., a leading global pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The transaction closed on June 4, 2025.
The Cravath team included partner Tatiana Lapushchik and associates Abhilasha Gokulan and Jasmine Hakimian.
Related Practices & Industries
People
- Photo
-
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.A., 1997, Barnard Collegesumma cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
June 05, 2025
Cencora, Inc.’s €1 Billion Registered Senior Notes Offering
Cravath represented the underwriters in connection with the €1 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on May 22, 2025.
Deals & Cases
December 23, 2024
Cencora, Inc.’s $1.8 Billion Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $1.8 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on December 9, 2024.
Deals & Cases
February 22, 2024
Cencora, Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on February 7, 2024.
